American Association for Cancer Research vii
Despite this sobering reality, federal policymakers can put
biomedical research back on course. To do so, however,
they must designate the NIH and NCI as national priorities
and provide these vitally important institutions with sustained
funding increases that are at least comparable to the
biomedical inflation rate. In addition, Congress must take action
to protect the agencies from sequestration, and to reinstate
the $1.6 billion in funding that the NIH lost in March 2013. The
AACR also calls upon its members, and indeed all Americans
— the beneficiaries of this lifesaving research — to make their
voices heard by contacting their representatives and senators
in Congress and urging them to vigorously support budget
increases for the NIH and NCI. If policymakers fail to act, our
ability to transform cancer care for the benefit of current and
future cancer patients will be seriously compromised, and
the crucial investments we have already made in biomedical
research will be jeopardized.
The inspiring personal stories of the cancer survivors in this
report are a testament to the value and importance of the
biomedical research that is supported by the NIH and NCI.
The AACR is deeply grateful to these courageous survivors for
both their participation and willingness to share their stories.
We stand with them and with patients and their loved ones
everywhere in calling upon our policymakers to make every
possible effort to help eradicate cancer. We ask you to join us
in this quest to conquer cancer.
Charles L. Sawyers, M.D.
Margaret Foti, Ph.D., M.D. (h.c.)
Chief Executive Officer
for Cancer Research
The mission of the American Association for Cancer Research
(AACR) is to prevent and cure cancer through research,
education, communication, and collaboration. Founded in 1907,
the AACR is the world’s oldest and largest scientific organization
dedicated to advancing cancer research for the benefit of
Its membership includes 34,000 laboratory, translational, and
clinical researchers who are working on every aspect of cancer
research; other health care professionals; and cancer survivors
and patient advocates in the United States and more than 90
countries outside the U.S. The AACR marshals the full spectrum
of expertise from the cancer community to accelerate progress in
the prevention, etiology, early detection, diagnosis, and treatment
of cancer through innovative scientific and educational programs
and publications. It funds innovative, meritorious research grants
to both senior and junior researchers, research fellowships for
scholars-in-training, and career development awards.
The AACR Annual Meeting attracts over 18,000 participants
who share the latest discoveries and new ideas in the field.
Special Conferences throughout the year present novel data
across a wide variety of topics in cancer research, ranging
from the laboratory to the clinic to the population. The AACR
publishes eight major peer-reviewed journals: Cancer Discovery;
Cancer Research; Clinical Cancer Research; Molecular Cancer
Therapeutics; Molecular Cancer Research; Cancer Epidemiology,
Biomarkers & Prevention; Cancer Prevention Research; and
Cancer Immunology Research. In 2012, the AACR’s scientific
journals received 20 percent of the total number of literature
citations in oncology.
The AACR also publishes a magazine, Cancer Today, for cancer
patients, survivors, patient advocates, and their families and
caregivers that includes essential, evidence-based information
and perspectives on progress in cancer research, survivorship,
and healthy lifestyle.
A major goal of the AACR is to educate the general public and
policymakers about the value of cancer research in improving
public health, the vital importance of increases in sustained
funding for cancer research, and the need for national policies
that foster innovation and progress in the field.
615 Chestnut Street, 17th floor
Philadelphia, PA 19106-4404
Telephone: (215) 440-9300
Fax: (215) 440-9313
AACR Office of Science Policy and Government Affairs
1425 K Street, NW, Suite 250
Washington, DC 20005
Telephone: (202) 898-6499
Fax: (202) 898-0966
©2013 American Association for Cancer Research.